BECTON DICKINSON & CO BDX
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1963-09-25
BECTON DICKINSON & CO insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Feld Michael | EVP, Chief Revenue Officer | 2026-06-26 | Sell | 75 | $152.80 |
| Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | 2026-06-24 | Sell | 1,100 | $145.66 |
| Garrison Michael David | EVP & Pres Med.Essntl&BioPharm | 2026-06-10 | Sell | 1,100 | $151.48 |
| Polen Thomas E Jr | Chairman, CEO and President | 2026-06-01 | Option exercise | 20,209 | $126.16 |
| Polen Thomas E Jr | Chairman, CEO and President | 2026-06-01 | Disposition | 17,445 | $146.15 |
| Polen Thomas E Jr | Chairman, CEO and President | 2026-06-01 | Sell | 2,764 | $146.35 |
| Menziuso Peter | EVP and President, BDI | 2026-06-01 | Grant | 14,258 | — |
| Feld Michael | EVP, Chief Revenue Officer | 2026-05-26 | Sell | 75 | $147.35 |
Source: SEC EDGAR filings · CIK 0000010795 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.